Shanghai ZJ Bio-Tech Co's book value per share for the quarter that ended in Mar. 2026 was ¥17.19.
During the past 12 months, Shanghai ZJ Bio-Tech Co's average Book Value Per Share Growth Rate was -6.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -6.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 7.60% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 28.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Shanghai ZJ Bio-Tech Co was 76.60% per year. The lowest was -6.90% per year. And the median was 35.45% per year.
During the past 13 years, the highest P/B Ratio of Shanghai ZJ Bio-Tech Co was 8.41. The lowest was 0.71. And the median was 1.22.
Good Sign:
Shanghai ZJ Bio-Tech Co Ltd stock PB Ratio (=0.93) is close to 1-year low of 0.88.
Shanghai ZJ Bio-Tech Co (SHSE:688317) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Shanghai ZJ Bio-Tech Co Book Value per Share Related Terms
Shanghai ZJ Bio-Tech Co Book Value per Share Historical Data
* Premium members only.
The historical data trend for Shanghai ZJ Bio-Tech Co's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai ZJ Bio-Tech Co Book Value per Share Chart
SHSE:688317 vs ABT, SYK, MDT: Book Value per Share Comparison
For the Medical Devices subindustry, Shanghai ZJ Bio-Tech Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai ZJ Bio-Tech Co PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shanghai ZJ Bio-Tech Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Shanghai ZJ Bio-Tech Co's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai ZJ Bio-Tech Co (SHSE:688317) has a Book Value per Share of ¥17.19 as of Mar. 2026. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Shanghai ZJ Bio-Tech Co and its competitors.
Is Shanghai ZJ Bio-Tech Co's Book Value per Share too high?
Shanghai ZJ Bio-Tech Co's current Book Value per Share is ¥17.19. Overall, Shanghai ZJ Bio-Tech Co has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai ZJ Bio-Tech Co's Book Value per Share compare to ABT and SYK?
Shanghai ZJ Bio-Tech Co's Book Value per Share of ¥17.19 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Medical Devices & Instruments company?
A good Book Value per Share depends on the Medical Devices & Instruments industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Shanghai ZJ Bio-Tech Co and its competitors. Shanghai ZJ Bio-Tech Co's current Book Value per Share is ¥17.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai ZJ Bio-Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai ZJ Bio-Tech Co (SHSE:688317) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥9.88, compared to a current price of ¥15.66 — trading 58.5% above its estimated fair value. The current Book Value per Share is ¥17.19. Shanghai ZJ Bio-Tech Co's overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Shanghai ZJ Bio-Tech Co (SHSE:688317), the current Book Value per Share is ¥17.19 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai ZJ Bio-Tech Co (SHSE:688317) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai ZJ Bio-Tech Co stock appears to be overvalued.
The current stock price of ¥15.66 is trading 58.5% above its estimated GF Value™ of ¥9.88.
GuruFocus considers Shanghai ZJ Bio-Tech Co to be Significantly Overvalued.
Key valuation signals for SHSE:688317:
Book Value per Share: ¥17.19
GF Value™: ¥9.88 vs. price of ¥15.66 (58.5% above fair value)
No single metric tells the full story. See the SHSE:688317 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai ZJ Bio-Tech Co Ltd is engaged in research and development, production and sales of genetic diagnostic reagents and instruments and equipment. The rapid real-time fluorescent PCR diagnostic test reagents developed by the company are mainly used in clinical medicine, public health emergencies, entry-exit inspection and quarantine, food inspection, animal husbandry, aquaculture and other fields.
64GF Score
Get the complete analysis for SHSE:688317
Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688317 has been successfully added to your 
